MINNEAPOLIS, Nov. 17, 2025 (GLOBE NEWSWIRE) -- Celcuity Inc. (Nasdaq: CELC), a clinical-stage biotechnology company pursuing development of targeted therapies for oncology, today announced the completion of the submission of its New Drug Application (“NDA”) to the U.S. Food and Drug Administration (“FDA”) for gedatolisib in hormone receptor positive (“HR+”), human epidermal growth factor receptor 2 negative (“HER2-”), advanced breast cancer (“ABC”). The NDA was submitted under the FDA's Real-Time Oncology Review (“RTOR”) program, which is intended to facilitate shorter regulatory review periods. Gedatolisib previously received both Breakthrough Therapy and Fast Track designations based on promising preliminary clinical data. The …

SINGAPORE--(BUSINESS WIRE)--Seagate Technology Holdings plc (NASDAQ: STX), a leading innovator of mass-capacity data storage, announced that management is scheduled to participate in the following investor events: Event: UBS Global Technology and AI Conference on Monday, December 1, 2025 Details: Presentation at 3:15 PM PT / 6:15 PM ET Event: Nasdaq 53rd Annual Investor Conference on Tuesday, December 9, 2025 Details: Presentation at 6:30 AM PT / 9:30 AM ET Management will be hosting investor m.

OMAHA, Neb.--(BUSINESS WIRE)--Werner Enterprises, Inc. (Nasdaq: WERN), one of the nation's largest transportation and logistics companies, announced today that its Board of Directors declared a regular quarterly cash dividend of $0.14 (fourteen cents) per common share. This dividend will be paid on January 21, 2026, to stockholders of record at the close of business on January 5, 2026. Werner Enterprises has paid a quarterly cash dividend to its stockholders every quarter since July 1987. Werne.

TULSA, Okla.--(BUSINESS WIRE)--Helmerich & Payne, Inc. (NYSE: HP) today announced that notice has been received to recommence operations on seven land rigs in Saudi Arabia that are currently under suspension. The reactivations will occur in stages throughout the first half of calendar year 2026. In accordance with the terms of the drilling contracts, all days accrued during each rig's suspension period will be added to its remaining contract. “These reactivations demonstrate the strong, lon.

ARLINGTON, Va.--(BUSINESS WIRE)--CoStar Group, Inc. (NASDAQ: CSGP), a leading provider of online real estate marketplaces, information, analytics, and 3D digital twin technology in the property markets, will present at Stephens 27th Annual Investment Conference. CFO Chris Lown and Head of Investor Relations Rich Simonelli will participate in a fireside chat on Thursday, November 20, 2025, at 9:00 a.m. CT. Live and recorded versions of the webcast will both be available under the Events & Pr.

SAN JOSE, Calif.--(BUSINESS WIRE)--Cadence announced the appointment of Dr. Luc Van den hove to its board of directors, effective January 1, 2026.

NELSONVILLE, Ohio--(BUSINESS WIRE)--Rocky Brands, Inc. (NASDAQ: RCKY) today announced that its board of directors has declared a quarterly cash dividend of $0.155 per share of outstanding common stock, which will be paid on December 15, 2025, to all shareholders of record as of the close of business on December 1, 2025. The declaration and payment of future dividends and the establishment of future record dates and payment dates are subject to the quarterly determination of the board of directo.

JASPER, Ind.--(BUSINESS WIRE)--Kimball Electronics, Inc. (Nasdaq: KE) today announced the Company will participate in the 7th Annual Wolfe Research Healthcare Conference, which is being held November 17-19, 2025, at the Wolfe Research offices in New York, NY. Richard D. Phillips, Chief Executive Officer, and Jana T. Croom, Chief Financial Officer, are scheduled to present on Tuesday, November 18, 2025, at 10:40 a.m. Eastern Time. A webcast of the presentation will be available on the Events &am.

OAKLAND, Calif.--(BUSINESS WIRE)--ThredUp (NASDAQ: TDUP, LTSE: TDUP), one of the largest online resale platforms for apparel, shoes, and accessories, today announced the appointment of Kelly Bodnar Battles to its Board of Directors, with the appointment becoming effective on December 1, 2025. Upon the effective date, Battles will assume the role of Audit Committee Chair. This appointment reinforces ThredUp's continued commitment to strengthening its financial governance as the company accelerat.

WARSAW, N.Y., Nov. 17, 2025 (GLOBE NEWSWIRE) -- Financial Institutions, Inc. (Nasdaq: FISI) (the “Company”), parent company of Five Star Bank and Courier Capital, LLC, announced that on November 14, 2025, its Board of Directors approved a quarterly cash dividend of $0.31 per outstanding common share.

CLEARWATER Fla., Nov. 17, 2025 (GLOBE NEWSWIRE) -- Apyx Medical Corporation (Nasdaq: APYX) (the “Company” or “Apyx Medical”) the leader in surgical aesthetics marketed and sold as Renuvion® and the AYON Body Contouring System™ (AYON), today announced that it is commencing an underwritten public offering of shares of its common stock (or common stock equivalents). The offering is subject to market conditions, and there can be no assurance as to whether or when the offering may be completed, or as to the actual size or terms of the offering.

NEW YORK, Nov. 17, 2025 (GLOBE NEWSWIRE) -- Tilray Brands, Inc. (“Tilray Brands”, “Tilray” or “the Company”) (Nasdaq: TLRY; TSX: TLRY), a global lifestyle and consumer packaged goods company at the forefront of the beverage, cannabis and wellness industries, today announced the release of its updated investor presentation, outlining the Company's strategic growth roadmap, category diversification, and financial performance milestones across its global platform.

Total revenue increased 13% year-over-year to $60.2 million, and adjusted EBITDA rose 20% to $5.1 million. Telehealth revenue grew 18% to $47.3 million, while telehealth adjusted EBITDA increased 30% to $2.9 million.

TORRANCE, Calif. , Nov. 17, 2025 (GLOBE NEWSWIRE) -- Navitas Semiconductor, an industry leader in next-generation GaNFast™ gallium nitride (GaN) and GeneSiC™ silicon carbide (SiC) power semiconductors, has announced participation in the following upcoming investor event:

Transaction Highlights Raised $975.0 million gross proceeds through a new offering of convertible senior notes due in November 2031 Has agreed to repurchase approximately $755.7 million principal amount of existing 1.25% convertible notes due in 2026 NEWARK, Calif. , Nov. 17, 2025 /PRNewswire/ -- Lucid Group, Inc. (Nasdaq: LCID), maker of the world's most advanced electric vehicles, today announced the closing of $975.0 million aggregate principal amount of convertible senior notes due 2031, including the exercise in full of the option granted to the initial purchasers to purchase up to $100.0 million aggregate principal amount of notes.

RENTON, Wash. , Nov. 17, 2025 /PRNewswire/ -- Radiant Logistics, Inc. (NYSE American: RLGT), a technology-enabled global transportation and value-added logistics services company, today announced that its board of directors has authorized the repurchase of up to five million shares of the Company's common stock through December 31, 2027.

MAUMEE, Ohio , Nov. 17, 2025 /PRNewswire/ -- The Andersons, Inc. (Nasdaq: ANDE) announces that it will present at the Stephens Annual Investment Conference on Wednesday, November 19, 2025. President and Chief Executive Officer Bill Krueger and Executive Vice President and Chief Financial Officer Brian Valentine will speak at the conference at 3 p.m.

MALVERN, Pa., Nov. 17, 2025 (GLOBE NEWSWIRE) -- TELA Bio, Inc. ("TELA Bio") (NASDAQ: TELA), a commercial-stage medical technology company focused on providing innovative soft-tissue reconstruction solutions, today announced that the Compensation Committee of the Board of Directors of TELA Bio approved inducement grants of (i) restricted stock units covering 30,200 shares of its common stock to seventeen newly-hired employees and (ii) an option to purchase 25,000 shares of its common stock to one employee, with a grant date of November 10, 2025 (the "Grant Date"). The equity awards were granted pursuant to the Nasdaq Rule 5635(c)(4) inducement grant exception …

NEEDHAM, Mass., Nov. 17, 2025 (GLOBE NEWSWIRE) -- Candel Therapeutics, Inc. (Candel or the Company) (Nasdaq: CADL), a clinical-stage biopharmaceutical company focused on developing multimodal biological immunotherapies to help patients fight cancer, today announced it will host a virtual Research and Development (R&D) Event from 11:00 am – 1:45 pm ET on Friday, December 5, 2025.

Largest real-world analysis of AI-driven breast cancer screening in US demonstrates increased cancer detection rate, consistency across patient populations